.@Pfizer ( $PFE ) and BioNTech ( $BNTX ) have announced today that its #Covid19 BNT162b1 &amp; BNT162b2 mRNA-based #vaccine candidates have received Fast Track designation from the US #FDA

$PFE $BNTX $MRNA $JNJ $INO $NVAX $IMV $EBS $ALNY $VIR #nasdaq #stocks https://t.co/lukuM9mnsJ